Literature DB >> 25795019

Comparative reactivity of the myeloperoxidase-derived oxidants HOCl and HOSCN with low-density lipoprotein (LDL): Implications for foam cell formation in atherosclerosis.

Fahd O Ismael1, Julie M Proudfoot2, Bronwyn E Brown1, David M van Reyk3, Kevin D Croft2, Michael J Davies4, Clare L Hawkins5.   

Abstract

Atherosclerosis is characterised by the accumulation of lipids within macrophages in the artery wall. Low-density lipoprotein (LDL) is the source of this lipid, owing to the uptake of oxidised LDL by scavenger receptors. Myeloperoxidase (MPO) released by leukocytes during inflammation produces oxidants that are implicated in atherosclerosis. Modification of LDL by the MPO oxidant hypochlorous acid (HOCl), results in extensive lipid accumulation by macrophages. However, the reactivity of the other major MPO oxidant, hypothiocyanous acid (HOSCN) with LDL is poorly characterised, which is significant given that thiocyanate is the favoured substrate for MPO. In this study, we comprehensively compare the reactivity of HOCl and HOSCN with LDL, and show key differences in the profile of oxidative damage observed. HOSCN selectively modifies Cys residues on apolipoprotein B100, and oxidises cholesteryl esters resulting in formation of lipid hydroperoxides, 9-hydroxy-10,12-octadecadienoic acid (9-HODE) and F2-isoprostanes. The modification of LDL by HOSCN results macrophage lipid accumulation, though generally to a lesser extent than HOCl-modified LDL. This suggests that a change in the ratio of HOSCN:HOCl formation by MPO from variations in plasma thiocyanate levels, will influence the nature of LDL oxidation in vivo, and has implications for the progression of atherosclerosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cholesterol; Low-density lipoprotein; Myeloperoxidase; Oxidation; Thiocyanate

Mesh:

Substances:

Year:  2015        PMID: 25795019     DOI: 10.1016/j.abb.2015.03.008

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Linking Inflammation and Parkinson Disease: Hypochlorous Acid Generates Parkinsonian Poisons.

Authors:  Thomas M Jeitner; Mike Kalogiannis; Boris F Krasnikov; Irving Gomolin; Morgan R Peltier; Graham R Moran
Journal:  Toxicol Sci       Date:  2016-03-29       Impact factor: 4.849

2.  Role of Myeloperoxidase Oxidants in the Modulation of Cellular Lysosomal Enzyme Function: A Contributing Factor to Macrophage Dysfunction in Atherosclerosis?

Authors:  Fahd O Ismael; Tessa J Barrett; Diba Sheipouri; Bronwyn E Brown; Michael J Davies; Clare L Hawkins
Journal:  PLoS One       Date:  2016-12-20       Impact factor: 3.240

3.  Low-density lipoprotein modified by myeloperoxidase oxidants induces endothelial dysfunction.

Authors:  Adrian I Abdo; Benjamin S Rayner; David M van Reyk; Clare L Hawkins
Journal:  Redox Biol       Date:  2017-08-05       Impact factor: 11.799

4.  Sodium thiocyanate treatment attenuates atherosclerotic plaque formation and improves endothelial regeneration in mice.

Authors:  Andreas Zietzer; Sven Thomas Niepmann; Bakary Camara; Monika Anna Lenart; Felix Jansen; Marc Ulrich Becher; René Andrié; Georg Nickenig; Vedat Tiyerili
Journal:  PLoS One       Date:  2019-04-02       Impact factor: 3.240

Review 5.  Lipoproteins as targets and markers of lipoxidation.

Authors:  Catarina B Afonso; Corinne M Spickett
Journal:  Redox Biol       Date:  2018-12-06       Impact factor: 11.799

Review 6.  Contribution of Predictive and Prognostic Biomarkers to Clinical Research on Chronic Kidney Disease.

Authors:  Michele Provenzano; Salvatore Rotundo; Paolo Chiodini; Ida Gagliardi; Ashour Michael; Elvira Angotti; Silvio Borrelli; Raffaele Serra; Daniela Foti; Giovambattista De Sarro; Michele Andreucci
Journal:  Int J Mol Sci       Date:  2020-08-14       Impact factor: 5.923

Review 7.  Role of Myeloperoxidase in Patients with Chronic Kidney Disease.

Authors:  Bojana Kisic; Dijana Miric; Ilija Dragojevic; Julijana Rasic; Ljiljana Popovic
Journal:  Oxid Med Cell Longev       Date:  2016-04-03       Impact factor: 6.543

8.  Hypochlorite-Modified Albumin Upregulates ICAM-1 Expression via a MAPK-NF-κB Signaling Cascade: Protective Effects of Apocynin.

Authors:  Dong-dong Tang; Hong-xin Niu; Fen-fen Peng; Hai-bo Long; Zong-rui Liu; Hao Zhao; Yi-hua Chen
Journal:  Oxid Med Cell Longev       Date:  2016-01-10       Impact factor: 6.543

Review 9.  The Anti-Inflammatory Effect of Taurine on Cardiovascular Disease.

Authors:  Tawar Qaradakhi; Laura Kate Gadanec; Kristen Renee McSweeney; Jemma Rose Abraham; Vasso Apostolopoulos; Anthony Zulli
Journal:  Nutrients       Date:  2020-09-17       Impact factor: 5.717

Review 10.  Leonurine, a potential drug for the treatment of cardiovascular system and central nervous system diseases.

Authors:  Lu Huang; Ding-Qiao Xu; Yan-Yan Chen; Shi-Jun Yue; Yu-Ping Tang
Journal:  Brain Behav       Date:  2020-12-10       Impact factor: 3.405

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.